Advanced search
Add to list

Design and baseline characteristics of the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) study (vol 16, pg 389, 2003)

(2004) CEREBROVASCULAR DISEASES. 17(1). p.91-92
Author
Organization

Citation

Please use this url to cite or link to this publication:

MLA
CLARK, W, A DAVALOS, and L GOLDSTEIN. “Design and Baseline Characteristics of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Study (vol 16, Pg 389, 2003).” CEREBROVASCULAR DISEASES 2004 : 91–92. Print.
APA
CLARK, W., DAVALOS, A., & GOLDSTEIN, L. (2004). Design and baseline characteristics of the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) study (vol 16, pg 389, 2003). CEREBROVASCULAR DISEASES. KARGER.
Chicago author-date
CLARK, W, A DAVALOS, and L GOLDSTEIN. 2004. “Design and Baseline Characteristics of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Study (vol 16, Pg 389, 2003).” Cerebrovascular Diseases. KARGER.
Chicago author-date (all authors)
CLARK, W, A DAVALOS, and L GOLDSTEIN. 2004. “Design and Baseline Characteristics of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Study (vol 16, Pg 389, 2003).” Cerebrovascular Diseases. KARGER.
Vancouver
1.
CLARK W, DAVALOS A, GOLDSTEIN L. Design and baseline characteristics of the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) study (vol 16, pg 389, 2003). CEREBROVASCULAR DISEASES. KARGER; 2004. p. 91–2.
IEEE
[1]
W. CLARK, A. DAVALOS, and L. GOLDSTEIN, “Design and baseline characteristics of the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) study (vol 16, pg 389, 2003),” CEREBROVASCULAR DISEASES, vol. 17, no. 1. KARGER, pp. 91–92, 2004.
@misc{391137,
  author       = {CLARK, W and DAVALOS, A and GOLDSTEIN, L},
  issn         = {1015-9770},
  language     = {eng},
  number       = {1},
  pages        = {91--92},
  publisher    = {KARGER},
  series       = {CEREBROVASCULAR DISEASES},
  title        = {Design and baseline characteristics of the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) study (vol 16, pg 389, 2003)},
  volume       = {17},
  year         = {2004},
}

Web of Science
Times cited: